Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,180
datasets available to search
ShareScore release 0.9.0
Dataset results
2,180 results for “Recombination”
Study of Subcutaneous Hydration Enabled by Human Recombinant Hyaluronidase (Hylenex)
ClinicalTrials.gov study NCT00656370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase
ClinicalTrials.gov study NCT01426763. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High
ClinicalTrials.gov study NCT02715804. IPD Sharing: Not stated. Countries: 22. Publications: 0.
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
ClinicalTrials.gov study NCT02172950. IPD Sharing: Not stated. Countries: 25. Publications: 0.
Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain
ClinicalTrials.gov study NCT04978454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
ClinicalTrials.gov study NCT06441578. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase
ClinicalTrials.gov study NCT00807885. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
ClinicalTrials.gov study NCT01848990. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
ClinicalTrials.gov study NCT04764084. IPD Sharing: YES. Countries: 1. Publications: 0.
A Comparison of Recombinant Human Brain Natriuretic Peptide and Dobutamine
ClinicalTrials.gov study NCT01837849. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex
ClinicalTrials.gov study NCT00000675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT04716374. IPD Sharing: NO. Countries: 0. Publications: 1.
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
ClinicalTrials.gov study NCT00000769. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B
ClinicalTrials.gov study NCT00093210. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy
ClinicalTrials.gov study NCT02767765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection
ClinicalTrials.gov study NCT00000663. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A
ClinicalTrials.gov study NCT00989196. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Recombinant Human IL-4 Receptor Used in Treatment of Asthma
ClinicalTrials.gov study NCT00017693. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/H
ClinicalTrials.gov study NCT00000866. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu)
ClinicalTrials.gov study NCT03293498. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.